NO781474L - Fremgangsmaate ved bestemmelse av ikke-bundne hormoner og farmasoeytika - Google Patents
Fremgangsmaate ved bestemmelse av ikke-bundne hormoner og farmasoeytikaInfo
- Publication number
- NO781474L NO781474L NO781474A NO781474A NO781474L NO 781474 L NO781474 L NO 781474L NO 781474 A NO781474 A NO 781474A NO 781474 A NO781474 A NO 781474A NO 781474 L NO781474 L NO 781474L
- Authority
- NO
- Norway
- Prior art keywords
- hormones
- hormone
- antibody
- unbound
- labeled
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 44
- 239000003814 drug Substances 0.000 title claims description 12
- 229940088597 hormone Drugs 0.000 claims description 79
- 239000005556 hormone Substances 0.000 claims description 79
- 239000000499 gel Substances 0.000 claims description 19
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 238000010828 elution Methods 0.000 claims description 14
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 11
- 102000014914 Carrier Proteins Human genes 0.000 claims description 11
- 108091008324 binding proteins Proteins 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 229920000642 polymer Polymers 0.000 claims description 10
- 239000011159 matrix material Substances 0.000 claims description 9
- 238000005259 measurement Methods 0.000 claims description 9
- 230000008961 swelling Effects 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 7
- 239000000178 monomer Substances 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- 230000027455 binding Effects 0.000 claims description 4
- 230000001900 immune effect Effects 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 3
- 229920002401 polyacrylamide Polymers 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 2
- 239000004952 Polyamide Substances 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 229940035676 analgesics Drugs 0.000 claims description 2
- 239000000730 antalgic agent Substances 0.000 claims description 2
- 239000003146 anticoagulant agent Substances 0.000 claims description 2
- 229940127219 anticoagulant drug Drugs 0.000 claims description 2
- 238000011088 calibration curve Methods 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229920002647 polyamide Polymers 0.000 claims description 2
- 239000003270 steroid hormone Substances 0.000 claims description 2
- 239000005495 thyroid hormone Substances 0.000 claims description 2
- 229940036555 thyroid hormone Drugs 0.000 claims description 2
- 229920006322 acrylamide copolymer Polymers 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 150000002338 glycosides Chemical class 0.000 claims 1
- 150000003873 salicylate salts Chemical class 0.000 claims 1
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 18
- 229960000890 hydrocortisone Drugs 0.000 description 12
- 239000000243 solution Substances 0.000 description 10
- 230000008569 process Effects 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 6
- 239000000700 radioactive tracer Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007863 gel particle Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 230000032258 transport Effects 0.000 description 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 description 1
- WCDJCWGYYQTMGO-OAHLLOKOSA-N (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-2,3,3-triiodopropanoic acid Chemical compound IC([C@](N)(C(=O)O)I)(C1=CC(I)=C(C(I)=C1)OC1=CC(I)=C(C(I)=C1)O)I WCDJCWGYYQTMGO-OAHLLOKOSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- WDJUZGPOPHTGOT-OAXVISGBSA-N Digitoxin Natural products O([C@H]1[C@@H](C)O[C@@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@@](C)([C@H](C6=CC(=O)OC6)CC5)CC4)CC3)CC2)C[C@H]1O)[C@H]1O[C@@H](C)[C@H](O[C@H]2O[C@@H](C)[C@@H](O)[C@@H](O)C2)[C@@H](O)C1 WDJUZGPOPHTGOT-OAXVISGBSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 1
- 108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000001837 anti-cortisol effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 108010024337 cortisol binding globulin Proteins 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 229960000648 digitoxin Drugs 0.000 description 1
- WDJUZGPOPHTGOT-XUDUSOBPSA-N digitoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O WDJUZGPOPHTGOT-XUDUSOBPSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 description 1
- 229960001348 estriol Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
- Y10S436/817—Steroids or hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2731028A DE2731028C2 (de) | 1977-07-08 | 1977-07-08 | Verwendung eines Antikörpergels zur immunologischen Bestimmung von Hormonen, Pharmaka und Vitaminen, welche in ungebundenem Zustand vorliegen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO781474L true NO781474L (no) | 1979-01-09 |
Family
ID=6013515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO781474A NO781474L (no) | 1977-07-08 | 1978-04-26 | Fremgangsmaate ved bestemmelse av ikke-bundne hormoner og farmasoeytika |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4235865A (fr) |
| JP (1) | JPS5417117A (fr) |
| AU (1) | AU519215B2 (fr) |
| BE (1) | BE866490A (fr) |
| BR (1) | BR7802601A (fr) |
| CA (1) | CA1108531A (fr) |
| CH (1) | CH642751A5 (fr) |
| CS (1) | CS200548B2 (fr) |
| DD (1) | DD136186A5 (fr) |
| DE (1) | DE2731028C2 (fr) |
| DK (1) | DK181578A (fr) |
| ES (1) | ES469641A1 (fr) |
| FI (1) | FI781221A (fr) |
| FR (1) | FR2396975A1 (fr) |
| GB (1) | GB1603773A (fr) |
| GR (1) | GR64475B (fr) |
| HU (1) | HU177805B (fr) |
| IE (1) | IE46809B1 (fr) |
| IL (1) | IL54559A (fr) |
| LU (1) | LU79533A1 (fr) |
| NL (1) | NL7804467A (fr) |
| NO (1) | NO781474L (fr) |
| NZ (1) | NZ187072A (fr) |
| PL (1) | PL111139B1 (fr) |
| SE (1) | SE7804802L (fr) |
| YU (1) | YU101078A (fr) |
| ZA (1) | ZA782357B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311687A (en) * | 1978-09-08 | 1982-01-19 | Corning Glass Works | Radiometric assay of dialysates |
| US4292296A (en) * | 1978-09-12 | 1981-09-29 | Baxter Travenol Laboratories, Inc. | Diagnostic method |
| DE3000483A1 (de) * | 1979-01-09 | 1980-07-17 | Fuji Photo Film Co Ltd | Mikrokapseln fuer immunologische bestimmungen |
| US4381291A (en) * | 1979-02-23 | 1983-04-26 | Ab Fortia | Measurement of free ligands |
| US4366143A (en) * | 1979-09-24 | 1982-12-28 | Amersham International Public Limited Company | Assay for the free portion of substances in biological fluids |
| US4391795A (en) * | 1980-03-21 | 1983-07-05 | Becton Dickinson And Company | Assay for free thyroid hormone |
| US4410633A (en) * | 1980-09-25 | 1983-10-18 | Corning Glass Works | Method for the measurement of free thyroxine or 3,5,3'-triiodothyronine in a liquid sample |
| IL63363A (en) * | 1981-07-20 | 1986-08-31 | Cais Michael | Non-centrifugation method for immunoassay of materials |
| US4558013A (en) * | 1983-04-08 | 1985-12-10 | Mast Immunosystems, Ltd. | Calibrated reaction measurement system |
| JPH042955U (fr) * | 1990-04-19 | 1992-01-10 | ||
| JPH0414452U (fr) * | 1990-05-21 | 1992-02-05 | ||
| WO2008106149A1 (fr) * | 2007-02-28 | 2008-09-04 | Children's Medical Center Corporation | Procédés de prédiction du début de la ménarche |
| WO2014120028A1 (fr) | 2013-01-29 | 2014-08-07 | Ux2 Centrum Technologiczne Sp. Z.O.O. | Élément de blocage d'ensemble de connexion pour éléments structuraux, ensemble de connexion avec éléments de blocage et procédé de liaison d'éléments structuraux au moyen dudit ensemble de connexion |
| KR102018084B1 (ko) | 2018-03-02 | 2019-09-04 | 주식회사 만도 | 차량의 조향 장치 및 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966897A (en) * | 1973-04-02 | 1976-06-29 | Marine Colloids, Inc. | Medium for use in bioassay and method of using same |
| US3925017A (en) * | 1973-05-01 | 1975-12-09 | Wisconsin Alumni Res Found | Preparation of dry, porous gel particles having high water regain for liquid sampling |
| US4039652A (en) * | 1973-10-11 | 1977-08-02 | Miles Laboratories, Inc. | Column method of immunoassay employing an immobilized binding partner |
| US4061466A (en) * | 1974-10-16 | 1977-12-06 | Ingvar Gosta Holger Sjoholm | Biologically active composition and the use thereof |
-
1977
- 1977-07-08 DE DE2731028A patent/DE2731028C2/de not_active Expired
-
1978
- 1978-04-19 GR GR56026A patent/GR64475B/el unknown
- 1978-04-20 YU YU01010/78A patent/YU101078A/xx unknown
- 1978-04-20 FI FI781221A patent/FI781221A/fi not_active Application Discontinuation
- 1978-04-20 IL IL54559A patent/IL54559A/xx unknown
- 1978-04-21 AU AU35363/78A patent/AU519215B2/en not_active Expired
- 1978-04-24 US US05/899,706 patent/US4235865A/en not_active Expired - Lifetime
- 1978-04-25 ZA ZA00782357A patent/ZA782357B/xx unknown
- 1978-04-26 NO NO781474A patent/NO781474L/no unknown
- 1978-04-26 CH CH454378A patent/CH642751A5/de not_active IP Right Cessation
- 1978-04-26 DK DK781815A patent/DK181578A/da not_active Application Discontinuation
- 1978-04-26 BR BR7802601A patent/BR7802601A/pt unknown
- 1978-04-26 LU LU79533A patent/LU79533A1/de unknown
- 1978-04-26 CA CA302,084A patent/CA1108531A/fr not_active Expired
- 1978-04-26 NZ NZ187072A patent/NZ187072A/xx unknown
- 1978-04-26 NL NL7804467A patent/NL7804467A/xx not_active Application Discontinuation
- 1978-04-26 FR FR7812345A patent/FR2396975A1/fr active Granted
- 1978-04-26 SE SE7804802A patent/SE7804802L/xx unknown
- 1978-04-27 BE BE187208A patent/BE866490A/fr not_active IP Right Cessation
- 1978-04-27 IE IE836/78A patent/IE46809B1/en unknown
- 1978-04-27 GB GB16823/78A patent/GB1603773A/en not_active Expired
- 1978-04-27 ES ES469641A patent/ES469641A1/es not_active Expired
- 1978-04-27 CS CS782722A patent/CS200548B2/cs unknown
- 1978-04-27 JP JP5072778A patent/JPS5417117A/ja active Granted
- 1978-04-27 DD DD78205047A patent/DD136186A5/xx unknown
- 1978-04-27 PL PL1978206417A patent/PL111139B1/pl unknown
- 1978-04-27 HU HU78CA423A patent/HU177805B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL206417A1 (pl) | 1979-03-12 |
| GR64475B (en) | 1980-03-27 |
| YU101078A (en) | 1989-02-28 |
| FR2396975B1 (fr) | 1984-05-11 |
| JPS6229745B2 (fr) | 1987-06-27 |
| ES469641A1 (es) | 1979-01-01 |
| FI781221A (fi) | 1979-01-09 |
| CS200548B2 (en) | 1980-09-15 |
| BE866490A (fr) | 1978-08-14 |
| CA1108531A (fr) | 1981-09-08 |
| CH642751A5 (de) | 1984-04-30 |
| DE2731028A1 (de) | 1979-01-25 |
| IL54559A (en) | 1981-11-30 |
| SE7804802L (sv) | 1979-01-09 |
| IE46809B1 (en) | 1983-09-21 |
| GB1603773A (en) | 1981-11-25 |
| ZA782357B (en) | 1979-04-25 |
| BR7802601A (pt) | 1979-04-17 |
| IL54559A0 (en) | 1978-07-31 |
| HU177805B (en) | 1981-12-28 |
| LU79533A1 (de) | 1978-09-29 |
| PL111139B1 (en) | 1980-08-30 |
| JPS5417117A (en) | 1979-02-08 |
| AU519215B2 (en) | 1981-11-19 |
| FR2396975A1 (fr) | 1979-02-02 |
| NL7804467A (nl) | 1979-01-10 |
| DE2731028C2 (de) | 1986-09-04 |
| DK181578A (da) | 1979-01-09 |
| AU3536378A (en) | 1979-10-25 |
| NZ187072A (en) | 1980-10-24 |
| US4235865A (en) | 1980-11-25 |
| DD136186A5 (de) | 1979-06-20 |
| IE780836L (en) | 1979-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO781474L (no) | Fremgangsmaate ved bestemmelse av ikke-bundne hormoner og farmasoeytika | |
| US4292296A (en) | Diagnostic method | |
| US4090850A (en) | Apparatus for use in radioimmunoassays | |
| US3646346A (en) | Antibody-coated tube system for radioimmunoassay | |
| US3995019A (en) | Diagnostic reagent system | |
| CA1083958A (fr) | Methode et appareil automatique pour le dosage radio- immunologique d'echantillons liquides | |
| CN111413506A (zh) | 一种检测试纸条在制备检测pla2r抗体的试剂盒中的应用 | |
| EP0061857B1 (fr) | Test d'agglutination de particules | |
| US4128628A (en) | Automated immunoassay | |
| Ørskov | Wick-chromatography for the immunoassay of insulin | |
| WO2023179804A1 (fr) | Méthode de détermination de la teneur en substance libre à l'aide d'une conversion ultrafiltration-dialyse à équilibre | |
| CN105067599A (zh) | 一种检测胃泌素释放肽前体的化学发光免疫检测试剂盒 | |
| NO781473L (no) | Polymermatriks basert paa akrylamid. | |
| US3710117A (en) | Vitro test system for assessing thyroid function | |
| AT371606B (de) | Immunologische bestimmung von ungebundenen hormonen oder pharmaka | |
| Loriaux et al. | A simple, quick, solid-phase method for radioimmunoassay of plasma estradiol in late pregnancy and of plasma cortisol | |
| Updike et al. | Gel entrapment of antibody: A new strategy for facilitating both manual and automated radioimmunoassay | |
| Abreau et al. | A single method for measuring total thyroxine and free thyroxine index in serum | |
| Connolly et al. | Screening radioimmunoassay for aldosterone in preheated plasma without extraction and chromatography. | |
| Boguslaski et al. | A column radioimmunoassay method for the determination of digoxin | |
| Bluett et al. | Simultaneous radioimmunoassay of thyrotropin and thyroxine in human serum. | |
| Zwart et al. | Determination of total hemoglobin in whole blood: further tests of the" Hemocue" method. | |
| Coleman et al. | Triiodothyronine uptake assay with immobilized triiodothyronine antibody as the bound-free separating agent. | |
| Ertingshausen et al. | The Union Carbide Centria® System | |
| RU2090892C1 (ru) | Способ определения биологически активных веществ |